Pretreatment of transfused donor splenocytes and allografts with mitomycin c attenuates acute rejection in heart transplantation in mice

Transplantation Proceedings

Volumn 46, Issue 4, 2014, Pages 1169-1174

  Liu, L ^a   Wang, F ^a   Zheng, Y ^a   Yuan, X ^a   Wang, D ^a   Zeng, W ^a   He, X ^a   Wang, C ^a   Deng, S ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BLOOD TRANSFUSION; CARDIAC GRAFT REJECTION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHIL; FLOW CYTOMETRY; FOXP3 REGULATORY T CELL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART TRANSPLANTATION; HISTOPATHOLOGY; IN VITRO STUDY; KAPLAN MEIER METHOD; LYMPH NODE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; SPLEEN CELL; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DRUG EFFECTS; GRAFT REJECTION; HEART; IMMUNOLOGY; PATHOLOGY; TIME; TRANSPLANTATION;

ACUTE DISEASE; ALLOGRAFTS; ANIMALS; APOPTOSIS; GRAFT REJECTION; GRAFT SURVIVAL; HEART; HEART TRANSPLANTATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; MITOMYCIN; SPLEEN; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 84900324176     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.11.052     Document Type: Conference Paper

References (22)

1. M. Arias, D. Seron, F. Moreso, O. Bestard, and M. Praga Chronic renal allograft damage: existing challenges Transplantation 91 9 Suppl 2011 S4 S25
2. B.J. Nankivell, and D.R. Kuypers Diagnosis and prevention of chronic kidney allograft loss Lancet 378 9800 2011 1428 1437
3. S.P. Cobbold, and X.C. Li Translating tolerogenic therapies to the clinic - where do we stand and what are the barriers? Front Immunol 3 2012 317
4. F. Issa, and K.J. Wood Translating tolerogenic therapies to the clinic - where do we stand? Front Immunol 3 2012 254
5. D. Wang, C. Kleist, S. Ehser, G. Opelz, and P. Terness Ex vivo perfusion with mitomycin C containing solution prolongs heart graft survival in rats Transplantation 82 2006 1537 1540
6. + memory T cells in nude mice Immunol Invest 39 8 2010 807 819
7. Y. Wang, Q. Qin, J. Chen, X. Kuang, J. Xia, and B. Xie et al. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice Transpl Immunol 22 2009 5 11
8. K. Shimizu, U. Schonbeck, F. Mach, P. Libby, and R.N. Mitchell Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis J Immunol 165 2000 3506 3518
9. R.E. Billingham, L. Brent, and P.B. Medawar Actively acquired tolerance of foreign cells Nature 172 4379 1953 603 606
10. O. Salvatierra Jr., F. Vincenti, W. Amend, D. Potter, Y. Iwaki, and G. Opelz et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach Ann Surg 192 1980 543 552
11. G. Opelz, and P.I. Terasaki Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions Lancet 2 7882 1974 696 698
12. 2 production Transplantation 70 2000 1788 1796
13. T. Misao, T. Udaka, M. Aoe, H. Date, A. Andou, and N. Shimizu Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts J Heart Lung Transplant 16 1997 1099 1105
14. G. Zhang, G. Chen, L. Liu, J. Qiu, and L. Chen A novel accelerated rejection model for mouse cardiac transplantation involving presensitization with donor splenocytes J Surg Res 181 2013 146 155
15. T. Tanigawa, M. Gotoh, H. Nagano, H. Ota, T. Fukuzaki, M. Sakon, and M. Monden Injection of mitomycin-C-treated spleen cells induces donor-specific unresponsiveness to cardiac allografts in rats Transplantation 67 1999 653 658
16. P. Terness, C. Kleist, H. Simon, F. Sandra-Petrescu, S. Ehser, and J.J. Chuang et al. Mitomycin C-treated antigen-presenting cells as a tool for control of allograft rejection and autoimmunity: from bench to bedside Hum Immunol 70 2009 506 512
17. Y.L. Huang, Y.Z. Wang, J.B. Chen, F. Wang, X.P. Kang, and J.J. Xia et al. Prevention of acute and chronic allograft rejection by combinations of tolerogenic dendritic cells Scand J Immunol 73 2011 91 101
18. K. Akiyama, C. Chen, D. Wang, X. Xu, C. Qu, and T. Yamaza et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis Cell Stem Cell 10 2012 544 555
19. L.P. Jiga, S. Ehser, C. Kleist, G. Opelz, and P. Terness Inhibition of heart allograft rejection with mitomycin C-treated donor dendritic cells Transplantation 83 2007 347 350
20. B. Li, Y. Koide, M. Uchijima, Y. Ohtawara, and K. Fujita Pretreatment of recipients with mitomycin-C-treated dendritic cells induces significant prolongation of cardiac allograft survival in mice Transplant Proc 34 2002 3426 3428
21. K. Wu, F. Xiang, J. Yuan, Z. Zeng, H. Zhou, S. Chang, and Z.K. Chen A combination of donor specific transfusion and rapamycin prolongs cardiac allograft survival in mice Transplant Proc 40 2008 3699 3701
22. T. Gunji, T. Saito, Y. Sato, S. Matsuyama, K. Ise, and T. Kimura et al. Mitomycin-C treatment followed by culture produces long-term survival of islet xenografts in a rat-to mouse model Cell Transplant 17 2008 619 629